CAR-T cells in solid tumors: engineering, biomarkers, translational pathways and the road ahead.

Al Shaer NSH, Masoud I, Tleyjeh A, Al-Attas AA, Al-Attas MA, Khan MI, Yaqinuddin A

Open source

DOI
10.3389/fimmu.2026.1796675
Published
2026
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1796675,
  title = {CAR-T cells in solid tumors: engineering, biomarkers, translational pathways and the road ahead.},
  author = {Al Shaer NSH and Masoud I and Tleyjeh A and Al-Attas AA and Al-Attas MA and Khan MI and Yaqinuddin A},
  year = {2026},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2026.1796675},
  url = {https://doi.org/10.3389/fimmu.2026.1796675}
}

RIS

TY  - JOUR
TI  - CAR-T cells in solid tumors: engineering, biomarkers, translational pathways and the road ahead.
AU  - Al Shaer NSH
AU  - Masoud I
AU  - Tleyjeh A
AU  - Al-Attas AA
AU  - Al-Attas MA
AU  - Khan MI
AU  - Yaqinuddin A
PY  - 2026
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2026.1796675
UR  - https://doi.org/10.3389/fimmu.2026.1796675
ER  - 

APA

NSH, A. S., I, M., A, T., AA, A., MA, A., MI, K., & A, Y. (2026). CAR-T cells in solid tumors: engineering, biomarkers, translational pathways and the road ahead.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1796675

Source records